Document Detail


Atypical neuroleptics and diabetes.
MedLine Citation:
PMID:  12909819     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Since a few years, an increasing number of cases of atypical neuroleptic-associated diabetes are reported in the literature. But few are dedicated to diabetologists. We report here two cases of patients with a severe deterioration of preexisting diabetes, with clozapine for the first case report and olanzapine for the second one. We also make a literature review and discuss the possible mechanisms involved in this atypical neuroleptic-associated diabetes. We recommend a thigh follow-up of weight, glycemic and lipidic parameters during psychotic patients treatment with atypical neuroleptics, in order to prevent or rapidly treat the metabolic complications described in the literature.
Authors:
S Béliard; R Valero; B Vialettes
Related Documents :
8161389 - Midgut volvulus: an unusual case of adolescent abdominal pain.
15359409 - Recurrent sigmoid volvulus in a sixteen-year-old boy: case report and review of the lit...
9819759 - Eosinophilic proliferative pylephlebitis in the liver of japanese beef cattle with fasc...
16689059 - Laboratory communication for restorative excellence.
10497629 - Thyrotoxic period paralysis: report of three cases and review of the literature.
2775369 - Extracorporeal shock-wave lithotripsy in hemophiliac patient.
20164009 - Imaging findings in idiopathic lobular granulomattous mastitis, case report and review ...
3457509 - Cytologic diagnosis of amniotic fluid embolism. report of a case with a unique cytologi...
19468449 - Primary adenocarcinoma of the seminal vesicle.
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  Diabetes & metabolism     Volume:  29     ISSN:  1262-3636     ISO Abbreviation:  Diabetes Metab.     Publication Date:  2003 Jun 
Date Detail:
Created Date:  2003-08-11     Completed Date:  2004-01-16     Revised Date:  2008-11-21    
Medline Journal Info:
Nlm Unique ID:  9607599     Medline TA:  Diabetes Metab     Country:  France    
Other Details:
Languages:  eng     Pagination:  296-9     Citation Subset:  IM    
Affiliation:
Service de Nutrition, Maladies métaboliques, Endocrinologie, Hôpital de Sainte Marguerite, Marseille, France. bvialettes@mail.ap-hm.fr
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adolescent
Antipsychotic Agents / adverse effects*
Benzodiazepines
Clozapine / adverse effects*
Diabetes Mellitus, Type 2 / chemically induced*
Disease Progression
Humans
Male
Middle Aged
Pirenzepine / adverse effects*,  analogs & derivatives*
Risk
Chemical
Reg. No./Substance:
0/Antipsychotic Agents; 12794-10-4/Benzodiazepines; 132539-06-1/olanzapine; 28797-61-7/Pirenzepine; 5786-21-0/Clozapine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Fish oil prevents the adrenal activation elicited by mental stress in healthy men.
Next Document:  Diabetic retinopathy in children and adolescents